medigraphic.com
ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)

2025, Number 4

<< Back Next >>

Rev Mex Anest 2025; 48 (4)

Malignant hypertermia, a rare entity to keep in mind

Bernaldo-de QCB, Pérez-Díaz A, Mosquera-Rodríguez E, Roca-Viéitez Ó

Language: Spanish
References: 4
Page: 280-282
PDF size: 339.35 Kb.





REFERENCES

  1. Rüffert H, Bastian B, Bendixen D, Girard T, Heiderich S, Hellblom A, et al. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group. Br J Anaesth. 2021;126(1):120-130. doi: 10.1016/j.bja.2020.09.029.

  2. Glahn KP, Ellis FR, Halsall PJ, Müller CR, Snoeck MM, Urwyler A, et al. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European malignant hyperthermia Group. Br J Anaesth. 2010;105:417-420.

  3. Hopkins PM, Cooke PJ, Clarke RC, Guttormsen AB, Platt PR, Dewachter P, et al. Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactions. Br J Anaesth. 2019;123:e29-e37. doi: 10.1016/j.bja.2019.02.029.

  4. Dlamini N, Voermans NC, Lillis S, Stewart K, Kamsteeg EJ, Drost G, et al. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscul Disord. 2013;23:540-548. doi: 10.1016/j.nmd.2013.03.008.




2020     |     www.medigraphic.com